At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,420 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post Market Observational Study to Obtain Additional Information on the Use of CorMatrix ECM for Pericardial Reconstruction
In Brief
An observational study for Coronary Disease. Completed, enrolled 1,420 participants across 43 sites.
Detailed Summary
The objective of the study is to actively gather additional information on the use of CorMatrix ECM for pericardial reconstruction.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 2014
Enrollment StartMar 2014
Primary CompletionDec 2017
TodayJul 2026
First PostedFeb 27, 2014
Enrollment StartMar 1, 2014
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 12.3 years ago